Literature DB >> 8503891

Over-expression of a functionally active human GM2-activator protein in Escherichia coli.

H Klima1, A Klein, G van Echten, G Schwarzmann, K Suzuki, K Sandhoff.   

Abstract

The cDNA of the human GM2-activator protein was cloned into the expression vector pHX17. The plasmid encodes a fusion protein with a hexahistidine tail and a Factor Xa cleavage site at its N-terminus. The recombinant protein was purified from cell homogenates under denaturing conditions by metal-ion affinity chromatography in a single step and then was refolded. The hexahistidine tail could be removed when desired by digestion with Factor Xa. In a functional assay, the GM2-activator thus generated from Escherichia coli and renatured, with or without the hexahistidine tail, was as active as the native GM2-activator protein that was purified from human tissue. When added to the culture medium, the recombinant carbohydrate-free GM2-activator, carrying the hexahistidine tail, could be taken up efficiently and restored the degradation of ganglioside GM2 to normal rates in mutant fibroblasts with the AB variant of GM2-gangliosidosis, which is characterized by a genetic defect in the GM2-activator protein. The prokaryotic expression system is useful for producing milligram quantities of a pure and functionally active GM2-activator.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503891      PMCID: PMC1134248          DOI: 10.1042/bj2920571

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  A T5 promoter-based transcription-translation system for the analysis of proteins in vitro and in vivo.

Authors:  H Bujard; R Gentz; M Lanzer; D Stueber; M Mueller; I Ibrahimi; M T Haeuptle; B Dobberstein
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

2.  Isolation and expression of a full-length cDNA encoding the human GM2 activator protein.

Authors:  B Xie; B McInnes; K Neote; A M Lamhonwah; D Mahuran
Journal:  Biochem Biophys Res Commun       Date:  1991-06-28       Impact factor: 3.575

3.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

4.  Beta-galactosidase from termination and deletion mutant strains.

Authors:  M R Villarejo; I Zabin
Journal:  J Bacteriol       Date:  1974-10       Impact factor: 3.490

5.  Mapping of the gene coding for the human GM2 activator protein to chromosome 5.

Authors:  J Burg; E Conzelmann; K Sandhoff; E Solomon; D M Swallow
Journal:  Ann Hum Genet       Date:  1985-01       Impact factor: 1.670

6.  Incorporation of ganglioside analogues into fibroblast cell membranes. A spin-label study.

Authors:  G Schwarzmann; P Hoffmann-Bleihauer; J Schubert; K Sandhoff; D Marsh
Journal:  Biochemistry       Date:  1983-10-11       Impact factor: 3.162

7.  Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A.

Authors:  E Conzelmann; K Sandhoff
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1979-12

8.  Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects.

Authors:  S Sonderfeld; E Conzelmann; G Schwarzmann; J Burg; U Hinrichs; K Sandhoff
Journal:  Eur J Biochem       Date:  1985-06-03

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  A simple and novel method for tritium labeling of gangliosides and other sphingolipids.

Authors:  G Schwarzmann
Journal:  Biochim Biophys Acta       Date:  1978-04-28
View more
  17 in total

1.  An alpha-subunit loop structure is required for GM2 activator protein binding by beta-hexosaminidase A.

Authors:  Maryam Zarghooni; Scott Bukovac; Michael Tropak; John Callahan; Don Mahuran
Journal:  Biochem Biophys Res Commun       Date:  2004-11-19       Impact factor: 3.575

2.  Molecular analysis of a GM2-activator deficiency in two patients with GM2-gangliosidosis AB variant.

Authors:  U Schepers; G Glombitza; T Lemm; A Hoffmann; A Chabas; P Ozand; K Sandhoff
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

3.  Hexosaminidase assays.

Authors:  Michaela Wendeler; Konrad Sandhoff
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

4.  Complete localization of disulfide bonds in GM2 activator protein.

Authors:  C G Schütte; T Lemm; G J Glombitza; K Sandhoff
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

5.  [Glycolipids of the cell surface--biochemistry of their decomposition].

Authors:  K Sandhoff; T Kolter
Journal:  Naturwissenschaften       Date:  1995-09

Review 6.  Glycosphingolipid degradation and animal models of GM2-gangliosidoses.

Authors:  T Kolter; K Sandhoff
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

7.  Recombinant GM2-activator protein stimulates in vivo degradation of GA2 in GM2 gangliosidosis AB variant fibroblasts but exhibits no detectable binding of GA2 in an in vitro assay.

Authors:  U Bierfreund; T Lemm; A Hoffmann; G Uhlhorn-Dierks; R A Childs; C T Yuen; T Feizi; K Sandhoff
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

Review 8.  Sphingolipids: the nexus between Gaucher disease and insulin resistance.

Authors:  Maria Fuller
Journal:  Lipids Health Dis       Date:  2010-10-11       Impact factor: 3.876

9.  Effect of structural modifications of ganglioside GM2 on intra-molecular carbohydrate-to-carbohydrate interaction and enzymatic susceptibility.

Authors:  Yu-Teh Li; Su-Chen Li; Makoto Kiso; Hideharu Ishida; Laura Mauri; Laura Raimondi; Anna Bernardi; Sandro Sonnino
Journal:  Biochim Biophys Acta       Date:  2007-10-05

10.  GM2 activator protein inhibits platelet activating factor signaling in rats.

Authors:  Brigitte Rigat; Herman Yeger; Darakhshanda Shehnaz; Don Mahuran
Journal:  Biochem Biophys Res Commun       Date:  2009-05-30       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.